BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 27768122)

  • 1. Differential contribution of the mitochondrial translation pathway to the survival of diffuse large B-cell lymphoma subsets.
    Norberg E; Lako A; Chen PH; Stanley IA; Zhou F; Ficarro SB; Chapuy B; Chen L; Rodig S; Shin D; Choi DW; Lee S; Shipp MA; Marto JA; Danial NN
    Cell Death Differ; 2017 Feb; 24(2):251-262. PubMed ID: 27768122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of small molecules on nuclear-encoded translation diseases.
    Soiferman D; Ayalon O; Weissman S; Saada A
    Biochimie; 2014 May; 100():184-91. PubMed ID: 24012549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic signatures uncover distinct targets in molecular subsets of diffuse large B cell lymphoma.
    Caro P; Kishan AU; Norberg E; Stanley IA; Chapuy B; Ficarro SB; Polak K; Tondera D; Gounarides J; Yin H; Zhou F; Green MR; Chen L; Monti S; Marto JA; Shipp MA; Danial NN
    Cancer Cell; 2012 Oct; 22(4):547-60. PubMed ID: 23079663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extension of chronological life span by reduced TOR signaling requires down-regulation of Sch9p and involves increased mitochondrial OXPHOS complex density.
    Pan Y; Shadel GS
    Aging (Albany NY); 2009 Jan; 1(1):131-45. PubMed ID: 20157595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma.
    Davis RE; Ngo VN; Lenz G; Tolar P; Young RM; Romesser PB; Kohlhammer H; Lamy L; Zhao H; Yang Y; Xu W; Shaffer AL; Wright G; Xiao W; Powell J; Jiang JK; Thomas CJ; Rosenwald A; Ott G; Muller-Hermelink HK; Gascoyne RD; Connors JM; Johnson NA; Rimsza LM; Campo E; Jaffe ES; Wilson WH; Delabie J; Smeland EB; Fisher RI; Braziel RM; Tubbs RR; Cook JR; Weisenburger DD; Chan WC; Pierce SK; Staudt LM
    Nature; 2010 Jan; 463(7277):88-92. PubMed ID: 20054396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FOXO1 is a TXN- and p300-dependent sensor and effector of oxidative stress in diffuse large B-cell lymphomas characterized by increased oxidative metabolism.
    Sewastianik T; Szydlowski M; Jablonska E; Bialopiotrowicz E; Kiliszek P; Gorniak P; Polak A; Prochorec-Sobieszek M; Szumera-Cieckiewicz A; Kaminski TS; Markowicz S; Nowak E; Grygorowicz MA; Warzocha K; Juszczynski P
    Oncogene; 2016 Nov; 35(46):5989-6000. PubMed ID: 27132507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The A3243G tRNALeu(UUR) MELAS mutation causes amino acid misincorporation and a combined respiratory chain assembly defect partially suppressed by overexpression of EFTu and EFG2.
    Sasarman F; Antonicka H; Shoubridge EA
    Hum Mol Genet; 2008 Dec; 17(23):3697-707. PubMed ID: 18753147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial translation factors of Trypanosoma brucei: elongation factor-Tu has a unique subdomain that is essential for its function.
    Cristodero M; Mani J; Oeljeklaus S; Aeberhard L; Hashimi H; Ramrath DJ; Lukeš J; Warscheid B; Schneider A
    Mol Microbiol; 2013 Nov; 90(4):744-55. PubMed ID: 24033548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of the antilymphoma activity of pracinostat reveals different sensitivities of DLBCL cells to HDAC inhibitors.
    Mensah AA; Spriano F; Sartori G; Priebe V; Cascione L; Gaudio E; Tarantelli C; Civanelli E; Aresu L; Rinaldi A; Damia G; Lovati E; Zucca E; Stathis A; Pietra C; Bertoni F
    Blood Adv; 2021 May; 5(10):2467-2480. PubMed ID: 33999145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of Toll-like receptor (TLR) and B cell receptor (BCR) signaling molecules in primary diffuse large B-cell lymphoma of the central nervous system.
    Akhter A; Masir N; Elyamany G; Phang KC; Mahe E; Al-Zahrani AM; Shabani-Rad MT; Stewart DA; Mansoor A
    J Neurooncol; 2015 Jan; 121(2):289-96. PubMed ID: 25391967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MYC Protein-positive Diffuse Large B-Cell Lymphoma Features an Activated B-Cell Receptor Signal Pathway.
    Wang WG; Jiang XN; Liu ZB; Zhou XY; Li XQ
    Am J Surg Pathol; 2017 Apr; 41(4):541-549. PubMed ID: 28291124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fyn kinase regulates translation in mammalian mitochondria.
    Koc EC; Miller-Lee JL; Koc H
    Biochim Biophys Acta Gen Subj; 2017 Mar; 1861(3):533-540. PubMed ID: 27940153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Ezrin-Radixin-Moesin proteins as novel regulators of pathogenic B-cell receptor signaling and tumor growth in diffuse large B-cell lymphoma.
    Pore D; Bodo J; Danda A; Yan D; Phillips JG; Lindner D; Hill BT; Smith MR; Hsi ED; Gupta N
    Leukemia; 2015 Sep; 29(9):1857-67. PubMed ID: 25801911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SIRT1 and HSP90α feed-forward circuit safeguards chromosome segregation integrity in diffuse large B cell lymphomas.
    Białopiotrowicz-Data E; Noyszewska-Kania M; Jabłońska E; Sewastianik T; Komar D; Dębek S; Garbicz F; Wojtas M; Szydłowski M; Polak A; Górniak P; Juszczyński P
    Cell Death Dis; 2023 Oct; 14(10):667. PubMed ID: 37816710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct clinical phenotypes associated with a mutation in the mitochondrial translation elongation factor EFTs.
    Smeitink JA; Elpeleg O; Antonicka H; Diepstra H; Saada A; Smits P; Sasarman F; Vriend G; Jacob-Hirsch J; Shaag A; Rechavi G; Welling B; Horst J; Rodenburg RJ; van den Heuvel B; Shoubridge EA
    Am J Hum Genet; 2006 Nov; 79(5):869-77. PubMed ID: 17033963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial and glycolytic metabolic compartmentalization in diffuse large B-cell lymphoma.
    Gooptu M; Whitaker-Menezes D; Sprandio J; Domingo-Vidal M; Lin Z; Uppal G; Gong J; Fratamico R; Leiby B; Dulau-Florea A; Caro J; Martinez-Outschoorn U
    Semin Oncol; 2017 Jun; 44(3):204-217. PubMed ID: 29248132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How Biophysical Forces Regulate Human B Cell Lymphomas.
    Apoorva F; Loiben AM; Shah SB; Purwada A; Fontan L; Goldstein R; Kirby BJ; Melnick AM; Cosgrove BD; Singh A
    Cell Rep; 2018 Apr; 23(2):499-511. PubMed ID: 29642007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL10 receptor is a novel therapeutic target in DLBCLs.
    Béguelin W; Sawh S; Chambwe N; Chan FC; Jiang Y; Choo JW; Scott DW; Chalmers A; Geng H; Tsikitas L; Tam W; Bhagat G; Gascoyne RD; Shaknovich R
    Leukemia; 2015 Aug; 29(8):1684-94. PubMed ID: 25733167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MYD88L265P augments proximal B-cell receptor signaling in large B-cell lymphomas via an interaction with DOCK8.
    Mandato E; Yan Q; Ouyang J; Paczkowska J; Qin Y; Hao Y; Bojarczuk K; Hansen J; Chapuy B; Rodig SJ; Khan SJ; Redd RA; Shipp MA
    Blood; 2023 Oct; 142(14):1219-1232. PubMed ID: 37467575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NLRX1 regulates TNF-α-induced mitochondria-lysosomal crosstalk to maintain the invasive and metastatic potential of breast cancer cells.
    Singh K; Roy M; Prajapati P; Lipatova A; Sripada L; Gohel D; Singh A; Mane M; Godbole MM; Chumakov PM; Singh R
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1460-1476. PubMed ID: 30802640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.